Rebalix
Invesco · sheet of 10 September 2026
Invesco · sheet of 10 September 2026ETF sheet · official issuer and register data
Invesco GBP Corporate Bond UCITS ETF Dist
IGCB · IE00BKW9SW28 · class Dist · GBP · domicile Ireland
Bonds · Corporate GBP · Broad (all maturities) · EuropeSFDR art. 6
Index tracked: Bloomberg Sterling Liquid Corporate Bond Index
- TER
- 0.10%+ trans. 0.08%
- Fund size
- 404 m EUR
- Tracking difference
- −0.13%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingquarterly
- Duration
- 5.53 yrsmedium (3–7 years)
Launch 5 Mar 2020 · costs from the KID as of 14 Aug 2026 · 578 securities held · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Redemption and Dealing of Shares:
The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges. Investment objective: The investment objective of the Fund is to achieve the total return…
Performance since series start (in euro) — base 100
5 Mar 2020 → 1 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +4.5% |
| 3 years | +18.0% |
| 5 years | −5.0% |
| 10 years | series too young |
| Since series start | −0.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 5.54% | 5.61% | 7.26% |
| Max drawdown | −5.33% | −6.24% | −30.64% |
| Sharpe | -0.81 | -0.42 | -1.02 |
| Sortino | -1.02 | -0.55 | -1.35 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IGCB · IE00BKW9SW281
RebalixIGCB · IE00BKW9SW28 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +6.97% | +7.14% | −0.16% |
| 2024 | +1.93% | +1.97% | −0.04% |
| 2023 | +9.70% | +9.88% | −0.19% |
| 2022 | −18.97% | −18.79% | −0.17% |
| 2021 | −3.52% | −3.34% | −0.18% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 100.0%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in GBP
Frequency: quarterly · last 12 months: 1.5915 GBP (6.72% of NAV) · last ex-date 10 Sept 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.9602 | — |
| 2025 | 4 | 1.2638 | +5.27% |
| 2024 | 4 | 1.245 | +5.03% |
| 2023 | 4 | 1.0575 | +4.48% |
| 2022 | 4 | 0.6048 | +2.03% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
IGBC · Börse Hamburg
+ 5 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BKW9SW28
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BKW9SW28
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IGCB · IE00BKW9SW282